Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

  title={Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study},
  author={Andrew C. Rice and Stephen Maton and . PostherpeticNeuralgiaStudyGroup1UKandRepublicofIre},
A multicentre double blind, randomised, placebo controlled 7-week study evaluated the efficacy and safety of gabapentin 1800 or 2400 mg/day in treating postherpetic neuralgia. Three hundred and thirty-four men and women aged at least 18 years (mean 73) received gabapentin 1800 or 2400 mg daily or placebo in three divided doses with a forced titration schedule. The primary outcome measure was change in average daily pain diary score (baseline week v final week). Secondary outcomes included mean… CONTINUE READING
Highly Influential
This paper has highly influenced 13 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS


Publications citing this paper.
Showing 1-10 of 126 extracted citations

Neuropathic Pain

PharmacoEconomics • 2009
View 20 Excerpts
Highly Influenced

Antiepileptic drugs: indications other than epilepsy.

Epileptic disorders : international epilepsy journal with videotape • 2004
View 3 Excerpts
Highly Influenced

Algorithm for neuropathic pain treatment : An evidence based proposal

N. B. Finnerupa, M. Ottob, H. J. McQuayc, T. S. Jensena, S. H. Sindrupb
View 2 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…